Integrated evaluation of targeted and non‐targeted therapies in a network meta‐analysis

Individualized therapies for patients with biomarkers are moving more and more into the focus of research interest when developing new treatments. Hereby, the term individualized (or targeted) therapy denotes a treatment specifically developed for biomarker‐positive patients.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Proctor, Tanja (VerfasserIn) , Jensen, Katrin (VerfasserIn) , Kieser, Meinhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2020
In: Biometrical journal
Year: 2020, Jahrgang: 62, Heft: 3, Pages: 777-789
ISSN:1521-4036
DOI:10.1002/bimj.201800322
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/bimj.201800322
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/bimj.201800322
Volltext
Verfasserangaben:Tanja Proctor, Katrin Jensen, Meinhard Kieser
Beschreibung
Zusammenfassung:Individualized therapies for patients with biomarkers are moving more and more into the focus of research interest when developing new treatments. Hereby, the term individualized (or targeted) therapy denotes a treatment specifically developed for biomarker‐positive patients.
Beschreibung:First published: 23 September 2019
Correction added on 28 October 2020, after first online publication: Projekt Deal funding statement has been added
Gesehen am 26.01.2021
Beschreibung:Online Resource
ISSN:1521-4036
DOI:10.1002/bimj.201800322